Iovance Biotherapeutics (2LB.STU) Q2 2026 Earnings

7MayConfirmed
Q1 2026
Next
-0.15
-0.15
-0.14
-0.13

Details

Expected EPS
-0.13102590960000002
Actual EPS
N/A
Surprise EPS
0.13
Surprise Percent
+100%

Description

Iovance Biotherapeutics (2LB.STU) will report earnings of for Q2 2026 on May 07, 2026.

0 Comments

Share your thoughts